download chevron-down chevron-right chevron-with-circle-down chevron-with-circle-up check circle-with-minus circle-with-plus export help-with-circle inbox link mail old-phone star-outlined star user v-card close close close Back to top
Top

Discharged on Antithrombotic Therapy

Last updated: May 3, 2018

CMS Measure ID: CMS104v6
Version: 6
NQF Number: None
Measure Description:

Ischemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge

Initial Patient Population:

Patients age 18 and older discharged from inpatient care (non-elective admissions) with a principal diagnosis of ischemic or hemorrhagic stroke and a length of stay less than or equal to 120 days that ends during the measurement period

Denominator Statement:

Patients with a principal diagnosis of Ischemic stroke

Denominator Exclusions:

*Patients with comfort measures documented

*Patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.

*Patients discharged to another hospital

*Patients who left against medical advice

*Patients who expired

*Patients discharged to home for hospice care

*Patients discharged to a health care facility for hospice care

Numerator Statement:

Patients prescribed or continuing to take antithrombotic therapy at hospital discharge

Numerator Exclusions:

Not Applicable

Denominator Exceptions:

Patients with a documented reason for not prescribing antithrombotic therapy at discharge

Measure Steward: The Joint Commission
Short Name: Stroke2
Next Version:
Previous Version:
Improvement Notation:

Improvement noted as an increase in rate

Guidance:

The Non-elective Inpatient Encounter value setinfo-icon intends to capture all non-scheduled hospitalizations. This value set is a subset of the Inpatient encounter value set, excluding concepts that specifically refer to elective hospital admissions. Non-elective admissions include emergency, urgent and unplanned admissions.

The Medication, Discharge datatype refers to the discharge medication list and is intended to express medications ordered for post-discharge use.

Notes: Value Set content updated Sept 2017

Specifications

Release Notes

Header

  • Incremented eMeasure Version number.

    Measure Section: eMeasure Version number

    Source of Change: Measure Lead

  • Replaced NQFinfo-icon Number '0435' with 'Not Applicable' as the measure is no longer endorsed.

    Measure Section: NQF Number

    Source of Change: Measure Lead

  • Replaced 'National Quality Forum' with 'None' as the measure is no longer endorsed.

    Measure Section: Endorsed By

    Source of Change: Measure Lead

  • ​Updated the Description header statement to better align with measure logic.

    Measure Section: Description

    Source of Change: JIRAinfo-icon (CQMinfo-icon-2457)

  • Updated Copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • ​Updated the Guidance narrative statement to better align with measure logic.

    Measure Section: Guidance

    Source of Change: JIRA (CQM-2457)

  • Added 'that ends during the measurement period' to the Initial Populationinfo-icon narrative statement to better align with measure logic.

    Measure Section: Initial Population

    Source of Change: JIRA (CQM-2520)

  • ​Updated the Numeratorinfo-icon narrative statement to better align with measure logic.

    Measure Section: Numerator

    Source of Change: JIRA (CQM-2457)

Logic

  • Replaced 'Antithrombotic ingredient specific' value setinfo-icon with 'Antithrombotic Therapy' semantic clinical drug value set to ease implementation burden.

    Measure Section: Denominator Exceptionsinfo-icon

    Source of Change: JIRA (CQM-1835)

Value Set

The VSACinfo-icon is the source of truth for the value set content, please visit the VSAC for downloads of current value setsinfo-icon.

  • Replaced Antithrombotic ingredient specific value set (2.16.840.1.113762.1.4.1021.8) with Antithrombotic Therapy value set (2.16.840.1.113883.3.117.1.7.1.201).

    Measure Section: QDMinfo-icon Data Elements

    Source of Change: JIRA (CQM-1835)

  • Value set Antithrombotic Therapy (2.16.840.1.113883.3.117.1.7.1.201): Added 23 RXNORM codes and deleted 34 RXNORM codes.

    Measure Section: QDM Data Elements

    Source of Change: Chart-Abstracted Measures

  • Value set Patient Refusal (2.16.840.1.113883.3.117.1.7.1.93): Added 3 SNOMEDCT codes (183946001, 183956002, 609589008).

    Measure Section: QDM Data Elements

    Source of Change: Measure Lead

  • Value set Hemorrhagic Stroke (2.16.840.1.113883.3.117.1.7.1.212): Deleted 2 ICD9CM codes (430, 431).

    Measure Section: QDM Data Elements

    Source of Change: Measure Lead

  • Value set Ischemic Stroke (2.16.840.1.113883.3.117.1.7.1.247): Deleted 12 ICD9CM codes.

    Measure Section: QDM Data Elements

    Source of Change: Measure Lead

  • Value set Antithrombotic Therapy (2.16.840.1.113883.3.117.1.7.1.201): Added 1 RXNORM code (1658717) and deleted 3 RXNORM codes (205251, 308287, 646434).

    Measure Section: QDM Data Elements

    Source of Change: 2018 Addendum

External Resources